A Phase I Study of Bavituximab, Capecitabine, and Radiation for the Treatment of Rectal Adenocarcinoma

NCT01634685 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

15

Enrollment

OTHER

Sponsor class

Conditions

Rectal Adenocarcinoma

Interventions

RADIATION: Radiation
DRUG: Bavituximab
DRUG: Capecitabine

Sponsor

University of Texas Southwestern Medical Center